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Introduction	
One	in	eight	women	living	in	developed	countries	will	be	diagnosed	with	breast	cancer	before	
the	age	of	85,	with	the	mean	age	at	first	diagnosis	approximately	60	years.	Stage	I	represents	
just	under	50%	of	diagnoses,	while	45%	of	cases	are	diagnosed	at	later	stages	ሺstages	II	to	IV;	
the	remainder	being	unknown	stageሻ	ሾ1‐3ሿ.	Breast	cancer	continues	to	be	the	most	common	
cause	of	cancer‐related	deaths	in	women	ሾ3,	4ሿ,	and	although	survival	for	women	with	stage	I	
disease	 is	 high	 ሺ98%	 5‐year	 relative	 survivalሻ,	 survival	 is	 significantly	 lower	 for	 those	
diagnosed	with	more	 advanced	 disease	 stage	 ሺi.e.,	 stages	 II	 to	 IV,	 83%;	 an	 unknown	 stage,	
50%ሻ	ሾ1,	3,	5ሿ.	
	
Natural	history	of	wellbeing	and	decline	after	breast	cancer	
Breast	cancer	 treatment	has	 long	been	associated	with	an	array	of	 significant	and	enduring	
physical	 and	 psychosocial	 consequences,	 including	 reduced	 upper‐body	 function,	 quality	 of	
life,	 poor	 body	 image,	 fatigue,	 increases	 in	 body	 weight	 and	 adverse	 changes	 to	 body	
composition	 ሾ6‐9ሿ.	Declines	 in	 fitness,	 physical	 and	psychosocial	 function	and	quality	of	 life	
typically	 occur	 during	 the	 active	 treatment	 period.	 Current	 conservative	 estimates	 from	 a	
prospective,	cohort	study	suggested	that	at	six	months	post‐diagnosis,	90%	of	women	report	
at	 least	 one	 significant	 adverse	 treatment	 effect	 ሺincluding	 fatigue,	 pain,	 lymphoedema,	
weight	 gainሻ	 and	 60%	 report	 multiple	 sequelae	 ሾ10ሿ.	 While	 outcomes	 improve	 following	
treatment	completion	and	up	to	approximately	12	months	post‐diagnosis	ሾ11ሿ,	 function	and	
fitness	typically	fail	to	reach	pre‐diagnosis	levels	and	remain	at	levels	lower	than	age‐matched	
norms	ሾ12ሿ.	Further,	beyond	the	18‐24	month	post‐diagnosis	period,	the	rate	of	‘typical’	age‐
related	 declines	 in	 fitness	 and	 function	 are	 faster	 for	women	who	 have	 had	 breast	 cancer,	
when	compared	with	age‐matched	normative	data	ሾ13ሿ.	
	
Physical	and	psychosocial	benefits	of	exercise		
Summarised	 in	multiple	meta‐analyses	 and	 systematic	 reviews,	 results	 from	 exercise	 trials	
involving	women	with	breast	cancer	clearly	demonstrate	that	exercising	during	and	following	
treatment	 leads	 to	 attenuation	 of	 treatment‐related	 morbidity	 and	 multiple	 physical	 and	
psychosocial	 health	 benefits,	 all	 of	 which	 optimise	 quality	 of	 life	 ሾ14,	 15ሿ.	 The	 clinical	
relevance	 of	 these	 findings	 are	 highlighted	 by	 data	 which	 demonstrate	 that	 outcomes	 of	
interest	improve	to	levels	higher	than	pre‐diagnosis	following	participation	in	exercise	during	
the	treatment	period;	and,	 levels	exceed	age‐matched	norms	following	participation	in	post‐
treatment	exercise	interventions	ሾ12ሿ.	Exercise	has	also	been	associated	with	reduced	risk	of	
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comorbidities	for	which	breast	cancer	survivors	are	at	increased	risk,	including	osteoporosis,	
diabetes,	 and	 heart	 disease	 ሾ16,	 17ሿ.	 Further,	 results	 of	 a	meta‐analysis	 of	 findings	 derived	
from	 cohort	 studies	 demonstrated	 that	 exercising	 post‐diagnosis	 is	 associated	 with	 41%	
reduced	all‐cause	mortality,	34%	fewer	breast	cancer	deaths,	and	24%	reduced	risk	of	disease	
recurrence;	this	effect	was	independent	of	other	prognostic	factors	including	stage	of	disease	
and	being	overweight	or	obese	ሾ18ሿ.	Thus,	incorporating	exercise	into	standard	breast	cancer	
care	has	real	potential	for	positively	influencing	the	lives	of	women	with	breast	cancer.	
	
Patterns	of	physical	activity	following	breast	cancer	diagnosis	
Evidence	from	population‐based	breast	cancer	cohort	studies	demonstrate	that	the	minority	
of	women	ሺ~30%ሻ	participate	 in	sufficient	 levels	of	physical	activity	ሺ൐150	minutes/weekሻ	
post‐diagnosis	and	the	majority	ሺ൐60%ሻ	experience	declines	in	exercise	levels	post‐diagnosis,	
with	 levels	 failing	 to	 return	 to	 pre‐diagnosis	 levels	 even	 2‐years	 post‐diagnosisሾ19‐21ሿ.	
Importantly,	insufficient	levels	of	exercise	and	declines	in	exercise	following	breast	cancer	are	
associated	 with	 higher	 rates	 of:	 fatigue,	 sleep	 disturbance,	 cognition	 problems,	 reduced	
upper‐body	 function	 and	 overall	 function,	 depression	 and	 anxiety,	 and	 lower	 quality	 of	 life	
ሾ10,	22‐25ሿ.	
	
Exercise	prescription	guidelines	
Numerous	 studies	 have	 been	 conducted	 among	women	with	 breast	 cancer	 and	 substantial	
evidence	 is	 now	 available	 from	 exercise	 trials	 for	 breast	 cancer	 survivors	 during	 and	 after	
treatment.	 Specifically,	 aerobic	 and	 resistance	 training	 is	widely	 accepted	 and	 promoted	 as	
safe	 and	 beneficial	 for	 women	 during	 and	 following	 breast	 cancer	 treatment	 ሾ26‐28ሿ.	 In	
practice,	 this	 advice	 is	 given	 in	writing	 and	 exercise	 is	 prescribed	 to	 be	 performed	 by	 the	
survivor	in	an	unsupervised	setting	ሺe.g.,	home	or	communityሻ.	At	best,	survivors	are	offered	
a	 brief	 program	 supervised	 by	 someone	 with	 minimal	 training	 in	 the	 potential	 risks	 of	
exercise	 after	 breast	 cancer.	 However,	 it	 has	 been	 suggested	 that	 a	 response	 bias	 exists	 in	
exercise	 intervention	 trials,	 with	 participants	 likely	 to	 be	 younger,	 healthier,	 and	 have	 a	
history	of	 exercise	participation,	 compared	with	 the	wider	breast	 cancer	 cohort.	 Therefore,	
questions	 remain	 about	 the	 appropriateness	 of	 these	 exercise	 guidelines	 for	 all	 women	
diagnosed	with	breast	cancer.	
	
Characteristics	 of	 participants	 in	 exercise	 intervention	 trials	 conducted	 during	 or	 following	
treatment:	findings	from	a	systematic	literature	review	
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We	performed	a	literature	review	to	compare	1ሻ	the	eligibility	criteria	of	exercise	and	breast	
cancer	 studies	 conducted	 during	 and	 following	 treatment	 for	 breast	 cancer	 and	 2ሻ	 the	
characteristics	of	recruited	samples	to	 the	 ‘typical’	breast	cancer	survivor.	We	hypothesized	
that	safety,	feasibility	and	potential	effect	of	exercise	during	or	following	treatment	for	breast	
cancer	 in	 a	 ‘typical’	 women	 with	 breast	 cancer	 ሺaged	 55‐60	 years,	 engages	 in	 insufficient	
levels	 of	 weekly	 physical	 activity,	 is	 overweight,	 has	 one	 or	more	 breast	 cancer	 treatment	
sequelae	and	may	also	have	another	comorbidity	ሾe.g.,	osteopenia,	hypertensionሿ,	figure	1ሻ	is	
yet	to	be	properly	established.		
	
The	meta‐analysis	by	Speck	et	al	ሺ2010ሻ	ሾ15ሿ	was	used	as	the	basis	for	the	database	search.	
Included	 studies	 were	 those	 published	 in	 English,	 included	 adult	 women	 diagnosed	 with	
breast	cancer	ሺstudies	 including	other	cancers	 in	addition	 to	breast	cancer	were	 included	 if	
the	 breast	 cancer	 data	 was	 reported	 separatelyሻ,	 evaluated	 an	 intervention	 designed	 to	
increase	physical	activity	and	included	a	concurrent	comparison	group.	PubMed	search	terms	
were	“ሺexercise	or	physical	activityሻ”	and	“cancer”,	with	31	March,	2014	defined	as	the	end	of	
the	 search	 period.	 Abstracts	 were	 reviewed	 to	 identify	 potentially	 eligible	 studies	 for	
inclusion	 in	 the	 review,	 with	 eligibility	 subsequently	 confirmed	 via	 review	 of	 full	 text.	
Inclusion	and	exclusion	criteria,	and	relevant	baseline	characteristics	of	 study	sample,	were	
extracted	for	each	study.	Where	possible,	baseline	characteristics	were	compared	with	United	
States	 of	 America,	 Canadian	 and	 Australian	 normative	 ranges	 for	 breast	 cancer	 survivors	
ሺdata	sourced	from	government	publications	and	longitudinal	cohort	studies,	ሾ2,	3,	29,	30ሿሻ.	
	
73	 studies	 met	 the	 criteria	 for	 inclusion	 in	 this	 literature	 review;	 25	 studies	 evaluating	
exercise	during	 treatment,	 and	48	studies	evaluating	exercise	after	breast	 cancer	 treatment	
ሺTable	1ሻ.	A	typical	exercise	program	in	these	studies	consisted	of	30	minutes	of	supervised,	
moderate‐intensity	aerobic	or	mixed	ሺaerobic	and	resistanceሻ	exercise,	three	times	a	week	for	
2‐3	months.	However,	the	prescriptive	characteristics	varied	greatly	across	studies	with	mode	
being	aerobic‐only,	resistance	only	or	mixed	type.	Aerobic‐based	exercise	was	prescribed	for	
durations	of	10‐60	minutes	per	session	and	20‐300	minutes/week	with	exercise	frequency	of	
1‐7	days	of	exercise/week.	Exercise	intensity	ranged	from	light	to	vigorous.	Resistance‐based	
exercise	prescription	ranged	from	1‐4	sets	of	6‐20	repetitions	at	intensities	of	50‐80%	of	one‐
repetition	 maximum,	 2‐3	 times	 per	 week,	 targeting	 small	 and	 large	 muscle	 groups.	 An	
example	 of	 a	 more	 novel	 exercise	 prescription	 was	 one	 that	 included	 additional	 exercises	
such	as	lower	body	impact	loading	involving	jumping	whilst	wearing	a	weighted	vestሾ31ሿ.	The	
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progression	 of	 the	 exercise	 program	 or	 the	 degree	 to	which	 programs	were	 individualized	
was	usually	not	well‐defined,	but	when	described	was	reflective	of	applying	standard	exercise	
prescription	principals.	
	
The	 majority	 of	 studies	 ሺ77%ሻሾ12,	 32‐86ሿ	 restricted	 eligibility	 on	 the	 basis	 of	 medical	
conditions,	 physical	 function,	 or	 treatment‐related	 sequelae	 ሺTable	 1ሻ,	 with	 studies	 listing	
between	one	and	eight	of	the	following	conditions	as	reasons	for	exclusions:	
 Comorbidities	 such	 as	 hypertension,	 cardiac	 conditions	 or	 cardiovascular	 disease,	
mental	 health	 issues	 ሺe.g.,	 anxiety	 or	 depression	 /psychiatric	 conditionsሻ,	 cognitive	
dysfunction,	 orthopedic	 conditions,	 obesity	 ሺvarious	 body	 mass	 index	 cut‐offsሻ,	
diabetes,	thyroid	disease,	renal	disease;	
 Treatment‐related	 sequelae	 such	 as	 severe	 nausea,	 low	 functional	 performance	 ሺe.g.	
Zubrod	 scale:	 “Symptomatic,	 ൐50%	 in	 bed,	 but	 not	 bedbound”ሻ,	 uncontrolled	 pain,	
lymphoedema,	 insomnia,	 infection	 risk,	 immune	 or	 endocrine	 abnormality	 or	 bony	
metastases;	and/or	
 A	 global	 exclusion	 statement	 relating	 to	 limited	 function	 or	 potential	 exercise	
contraindications.	 For	 example,	 “any	 medical	 ሺphysical	 and/or	 psychologicalሻ	
conditions	that	may	limit	participation”	ሺ60%	ሾ44/73ሿ	included	a	statement	similar	to	
this	in	the	exclusion	criteriaሻ.	
	
Four	 studies	 did	 not	 report	 any	 exclusion	 criteria	 ሾ31,	 87‐89ሿ	 and	 13	 studies	 targeted	
recruitment	 of	 women	 who	 had	 a	 specific	 condition	 or	 disease	 burden	 ሺincluding	 obesity	
ሾbased	 on	 BMIሿ	 ሾnൌ3ሿሾ90‐92ሿ,	 lymphoedema	 ሾnൌ3ሿሾ93‐95ሿ,	 low	 bone	 mineral	 density	
ሾnൌ2ሿሾ96,	 97ሿ,	 advanced/	 stage	 IV	 disease	 ሺnൌ1ሻሾ98ሿ,	 or	 high	 pain	 or	 fatigue,	 reduced	
function	or	 a	 combination	of	 these	 conditions	 ሾnൌ4ሿሾ86,	 99‐101ሿሻ.	 Thirty	 one	of	 73	 studies	
excluded	women	who	reported	regular	weekly	physical	activity	ሾ31,	36,	37,	41,	45,	47‐50,	53‐
56,	 58,	 62,	 64,	 65,	 68‐70,	 74‐79,	 82,	 84,	 86,	 92,	 102ሿሺeligibility	 definitions	 ranged	 from	
excluding	women	who	engaged	 in	physical	 activity	 one	or	more	 times	or	 for	more	 than	40	
minutes	 each	 week,	 to	 excluding	 only	 very	 active	 women	 ሾthose	 who	 engaged	 in	 ൒250	
minutes	 of	 moderate	 physical	 activity	 or	 equivalent	 each	 weekሿሻ.	 The	 average	 age	 of	
participants	 for	 the	majority	of	 studies	ሺ42/73ሻ	 ሾ31,	32,	37‐43,	45‐54,	57‐59,	61,	63,	66‐70,	
72‐74,	76,	78,	79,	84,	87,	88,	97,	98,	100,	101ሿ	was	younger	than	the	estimated	international	
average	 age	 of	 women	 diagnosed	 with	 breast	 cancer	 ሺ൏56	 years	 versus	 56‐61.5	 years,	
respectivelyሻ.	In	fact,	one	half	of	women	diagnosed	with	breast	cancer	in	the	United	states	are	
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aged	 over	 65	 years	 ሾ103ሿ.	 Almost	 one‐third	 of	 studies	 ሺnൌ20ሻ	 did	 not	 report	 on	 stage	 of	
disease	of	participants	ሾ32,	34,	35,	37,	43,	49,	51,	58,	59,	66,	71,	73,	80,	81,	84,	91‐93,	96,	99ሿሻ.	
For	those	studies	that	did	ሺnൌ53ሻ,	most	ሺ81%	ሾ12,	31,	33,	36,	38‐42,	44‐47,	50,	53‐55,	60,	61,	
63‐65,	 67‐70,	 72,	 74,	 75,	 79,	 82,	 83,	 85‐90,	 95,	 97,	 100,	 101ሿሻ	 recruited	 participants	 with	
stages	I‐III	breast	cancer,	with	the	proportions	of	women	with	stage	I	versus	II൅	considered	
similar	to	population	norms.	Three	studies	reported	inclusion	of	stage	IV	disease	ሾ56,	77,	98ሿ.	
	
Of	the	42	studies	that	did	not	exclude	women	based	on	baseline	physical	activity	 levels	ሾ12,	
32‐35,	38‐40,	42‐44,	46,	49,	51,	52,	57,	59‐61,	63,	66,	67,	71‐73,	80,	81,	83,	85,	87‐91,	94‐101ሿ,	
physical	 activity	 levels	 of	 the	 sample	 were	 only	 described	 in	 43%	 and	 46%	 of	 studies	
conducted	during	ሾ32,	37,	38,	42,	45,	49,	53ሿ	and	following	ሾ12,	60,	64,	65,	69,	72,	80,	83,	85,	
90,	 91,	 100ሿ	 treatment	 respectively.	 Of	 those	 that	 reported	 baseline	 physical	 activity	 data,	
between	 30‐60%	 of	 the	 samples	 were	 regularly	 active	 before	 commencement	 of	 the	
intervention.	Past	physical	activity	 level	ሺe.g.,	physical	activity	 levels	pre‐breast	cancerሻ	was	
reported	in	3	studies;	49‐75%	of	participants	in	these	studies	were	regularly	physically	active	
prior	 to	 breast	 cancer	 diagnosis	 ሾ40,	 51,	 80ሿ.	 The	 presence	 of	 comorbidities	 or	 treatment‐
related	sequelae	was	not	reported	by	any	included	study.	
	
No	 serious	 adverse	 events	were	 reported	 in	 any	 of	 the	 studies	 included	 in	 this	 systematic	
review.	Adverse	events	that	were	reported	were	the	similar	to	those	that	would	be	expected	
in	 a	 non‐cancer	 population	 and	 were	 considered	 minor	 and	 acute.	 Examples	 include	 an	
individual	mentioning	“knee	discomfort”ሾ87ሿ,	a	mild	hematoma	at	the	site	of	a	blood	draw	and	
two	participants	who	were	referred	to	their	usual	health	care	provider	due	to	elevated	blood	
pressure	during	a	 treadmill	 fitness	test	ሺthey	remained	 in	the	exercise	 intervention	with	no	
further	eventsሾ102ሿሻ.		
	
Implications	of	findings	
Findings	 from	 the	 systematic	 literature	 support	 the	 notion	 that	 women	 participating	 in	
exercise	 trials	 conducted	 during	 or	 following	 treatment	 for	 breast	 cancer	 tended	 to	 be	
younger,	more	likely	to	have	less	advanced	disease,	and	were	likely	to	be	more	well	than	the	
‘typical’	woman	with	breast	cancer.	Two	key	findings	support	this	suggestion.	First,	eligibility	
criteria	of	the	majority	of	studies	restricted	the	ability	to	recruit	samples	representative	of	the	
wider	breast	cancer	population.	For	example,	population	data	suggests	20%	of	women	aged	
50‐69	years	have	one	or	more	comorbidities	at	the	time	of	breast	cancer	diagnosis	and	this	
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rate	increases	to	55%	for	older	women	ሾ104ሿ.	The	most	common	comorbidities	across	all	age	
groups	of	women	with	breast	cancer	are	cardiovascular	disease,	diabetes,	chronic	obstructive	
pulmonary	disease	and	stroke	ሾ17,	104ሿ.	Yet,	these	are	the	same	concerns	listed	as	exclusion	
criteria	 for	 some	 studies	 included	 in	 the	 review.	 Second,	 based	 on	 reported	 sample	
characteristics,	 women	 in	 exercise	 trials	 were	 of	 younger	 age	 and	 few	 studies	 included	
women	with	advanced	disease.	
	
Quantifying	the	extent	ሺor	lack	thereofሻ	to	which	exercise	samples	were	representative	of	the	
wider	 breast	 cancer	 population	 was	 hindered	 by	 the	 lack	 of	 information	 reported	 on	
important	patient‐characteristics	including	pre‐diagnosis	and	baseline	physical	activity	levels,	
weight	 and	proportions	 in	 the	healthy	versus	overweight	 categories,	 as	well	 as	presence	of	
treatment‐related	side	effects	and/or	comorbidities.	However,	the	absence	of	this	information	
provides	 strength	 to	 the	 suggestion	 that	 findings	 from	 exercise	 intervention	 trials	 lack	
generalizability	 to	 the	wider	breast	cancer	population.	Evidence	 from	cohort	studies	clearly	
highlights	 the	 relationship	between	 lower	 levels	 of	 physical	 activity	post‐breast	 cancer	 and	
older	 age,	more	 advanced	 disease,	 presence	 of	 treatment‐related	 side	 effects	 and/or	 other	
comorbidities	ሾ105‐107ሿ.	Therefore,	it	can	be	assumed	that	women	with	these	characteristics	
would	be	 less	 likely	 to	volunteer	 for	participating	 in	an	exercise	 trial,	 and	 they	may	be	 less	
likely	 encouraged	 to	 do	 so	 by	 clinic	 staff.	 That	 is,	 time	 constraints	 within	 the	 clinic	 and	
competing	 priorities	 may	 influence	 the	 type	 of	 woman	 who	 ultimately	 gets	 invited	 to	
participate	in	an	exercise	trial.	For	example,	discussions	about	an	exercise	trial	would	be	more	
difficult	 to	 have	 with	 a	 woman	 who	 has	 upcoming	 adjuvant	 therapy	 and	 is	 dealing	 with	
lymphoedema,	 compared	with	 a	woman	who	 had	 a	 lumpectomy	 and	 sentinel	 node	 biopsy,	
and	has	no	treatment‐related	sequelae.	Unfortunately,	the	lack	of	inclusion	of	these	women	in	
exercise	 intervention	 trials	 could	 have	 implications	 to	 study	 findings	 relating	 to	 safety,	
feasibility	and	effect.	
	
While	 representativeness	 of	 findings	 derived	 from	 the	 broader	 exercise	 and	 breast	 cancer	
trial	 evidence‐base	 is	 questionnable,	 findings	 from	 individual	 exercise	 studies	 within	 and	
beyond	the	breast	cancer	setting	can	provide	some	understanding	about	safety,	feasibility	and	
efficacy	 of	 exercise.	 For	 example,	 supervised,	 progressive	 exercise	 programs	 have	 been	
demonstrated	 to	 be	 safe	 and	 feasible	 for	 bone	 marrow	 transplant	 patients	 ሾ108,	 109ሿ,	
colorectal	 cancer	patients	 ሾ110ሿ,	 and	women	undertaking	 chemotherapy	 for	 ovarian	 cancer	
ሾ111ሿ.	These	patient	groups	could	be	considered	more	unwell	than	the	average	woman	with	
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breast	 cancer.	 Further,	 non‐randomised	 trial	 evidence	 has	 demonstrated	 women	 with	
advanced	 breast	 cancer	 can	 safely	 and	 feasibly	 participate	 in	 exercise	 trials	 ሾ112,	 113ሿ.	
However,	 again,	 the	 exercise	 intervention	 tested	 was	 supervised	 and	 prescription	
individualised.	With	 respect	 to	 efficacy	 of	 exercise,	 it	 is	 plausible	 that	 the	 potential	 benefit	
accrued	through	exercise	is	in	the	conservative	direction.	More	advanced	disease,	presence	of	
comorbidities,	poorer	lifestyle	characteristics	and	more	problematic	recoveries	are	associated	
with	lower	levels	of	function,	fitness,	quality	of	life	and	survival.	Therefore,	assuming	exercise	
is	 safe	 and	 feasible,	 capacity	 for	 positive	 change	 via	 exercise	 is	 likely	much	 higher	 for	 the	
‘unwell’	woman	with	breast	cancer	compared	with	the	younger,	healthier	woman.	
	
Undoubtedly,	 the	 field	 of	 exercise	 and	 breast	 cancer	 has	 developed	 considerably	 since	 the	
pioneering	 studies	 published	 in	 the	 early	 1980s.	 Over	 time,	 sample	 sizes	 have	 generally	
increased,	 quality	 of	 design	 and	 reporting	 has	 improved	 significantly,	 cancer	 cohorts	 other	
than	 breast	 have	 been	 evaluated	 and	 findings	 from	 large	 efficacy,	 as	 well	 as	 effectiveness	
trials,	are	available.	The	findings	from	these	studies	have	provided	the	platform	from	which	
exercise	recommendations	 for	 cancer	 survivors	have	been	developed,	with	 these	guidelines	
endorsed	 and	 promoted	 by	 various	 national	 exercise	 and	 cancer	 organizations	 ሾ26‐28ሿ.	
However,	 it	 is	 important	 to	remember	 that	over	80%	of	participants	 in	exercise	and	cancer	
trials	are	women	with	breast	cancer	ሾ15ሿ	and	the	findings	from	the	review	presented	in	this	
commentary	 highlight	 the	 potential	 for	 participant	 bias,	 with	 that	 bias	 having	 potential	
implications	about	what	we	know	regarding	exercise	safety,	feasibility	and	effect.	
	
Recommendations	for	future	research		
To	continue	to	advance	knowledge,	pragmatic	studies	with	representative	samples	evaluating	
‘real‐world’	 exercise	 trials,	 as	 well	 as	 more	 studies	 with	 eligibility	 criteria	 that	 target	
subgroups	of	 the	breast	 cancer	population	 that	are	currently	under‐represented	 in	exercise	
trial,	are	needed.	Involving	oncology	clinical	professionals	as	stakeholders	in	future	research	
may	assist	with	understanding	why	referrals	occur	or	do	not	occur	within	the	population	of	
breast	cancer	survivors.	Further,	developing	an	understanding	as	to	why	women	participate	
in	exercise	trials	and/or	participate	in	regular	exercise	without	programmatic	support	would	
provide	useful	insight	into	how	to	get	and	keep	women	active	during	and	beyond	their	breast	
cancer	experience.	Findings	from	such	research	will	help	address	research	gaps	and	aid	the	
international	endeavor	of	incorporating	exercise	into	standard	cancer	care.	
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Table	 1.	 Number	 of	 exercise	 studies	 for	women	with	 breast	 cancer	 conducted	 during	 and	
after	treatment	with	specific	exclusion	criteria		
	
	
	
Studies	with	the	following	exclusion	criteria:	
Studies	of	exercise	trials
During	treatment		
(n=	25)a	
n	(%)	
After	treatment	
(n=48)b	
n	(%)	
Comorbidities	and	medical	conditions	
Obesity	(Body	Mass	Index >35,	>40	or	>50	kg/m2) 2	(8)
[47,	52]	
7	(15)
[54,	59,	75,	82,	83,	
95,	96]	
	
Hypertension	 9 (36)
[37‐39,	42,	43,	46,	
49,	51,	53]	
11	(23)
[12,	54,	60,	62,	72,	
73,	75,	80,	82,	100,	
101]	
	
Known	cardiac	disease	/uncontrolled/	severe/	cardiovascular	
disease	
14 (56)
[34,	35,	37‐39,	41,	
43‐49,	51]	
17	(35)
[12,	55,	60,	62,	67‐
69,	72,	73,	76‐80,	
84,	85,	102]	
	
Acute	or	chronic	respiratory	disease	 10 (40)
[34,	37,	41,	43‐49]	
3	(6)
[67,	84,	102]	
	
Psychological	or	psychiatric	disorders/	diseases	(current	
and/or	history)	
11 (44)
[33,	38‐40,	43‐45,	
50,	52,	53,	97]	
10	(21)
[12,	57,	60,	61,	70,	
78,	86,	92,	99,	102]
	
Neurological/	cognitive	dysfunction	 4 (16)
[37,	47‐49]	
1	(2)
[99]	
	
Thyroid	disease/uncontrolled	 0	(0) 2	(4)
[12,	60]	
	
Diabetes/type	II	diabetes 1	(4)
[53]	
9	(19)
[12,	60,	64,	65,	68,	
73,	76‐78]	
	
Renal	or	hepatic	disease	 1	(4)
[97]	
0	(0)
Major	orthopaedic	limitations/verified	osteoporosis/	severe	
arthritis/high	risk	of	fracture	
3	(12)
[35,	50,	52,	97]	
12	(25)
[31,	55,	69,	72,	76,	
78‐80,	85,	92,	100,	
101]	
	
Symptomatic	bone	metastases/	known	metastatic	disease 4	(16)
[44,	45,	97,	98]	
12	(25)
[12,	57,	58,	61,	67,	
72,	73,	79‐81,	86,	
102]	
	
Infection,	immune	or	endocrine	abnormality 2	(8)
[50,	98]	
7	(15)
[12,	60,	67,	80,	96,	
101,	102]	
	
Disease‐	and	treatment‐related	sequelae
Insomnia	 0	(0) 1	(2)
[61]	
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Severe	nausea	 1	(4)
[52]	
	
1	(2)
[92]	
	
Anorexia	 0	(0) 1	(2)
[92]	
	
Lymphoedema	 0	(0) 2	(4)
[62,	101]	
	
Uncontrolled	pain/	bone	pain/	>	2	on	0‐10	pain	scale 2	(8)
[52,	98]	
1	(2)
[62]	
	
Abnormal	levels	in	blood	tests	 1 (4)
[46]	
	
0	(0)
Incomplete	axillary	surgery	/	trans‐abdominal	rectus	
abdominus	muscle	reconstructive	surgery	
2 (8)
[38,	39]	
	
0	(0)
General	exclusion	relating	to	physical	function,	overall	health	
and/or	ability	to	exercise,	e.g.,	“any	medical	(physical	and/or	
psychological)	conditions	that	may	limit	participation”	
16 (64)
[33‐36,	40‐48,	52,	
53,	97]	
28	(58)
[54,	56,	58,	59,	61,	
62,	67,	68,	70,	72‐
80,	82‐86,	90,	91,	
96,	99,	102]	
	
a	[32‐53,	87,	97,	98]	
b	[12,	31,	54‐86,	88‐96,	99‐102]	
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Figure	1.	The	characteristics	of	the	typical	woman	with	breast	cancer	
a	The	data	used	to	determine	these	characteristics	come	from	population	norm	data	as	well	as	
findings	from	cohort	studies	describing	women	post	breast	cancer.
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